Medical Footwear Market Segmented By Medical Shoes & Boots, Medical Sandals Product in Medical Footwear for Men, Medical Footwear for Women, Unisex Medical Footwear
Industry: Consumer Goods
Published Date: December-2022
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 300
Report ID: PMRREP32871
The global medical footwear market is projected to expand at ~5.4% CAGR and reach ~US$ 19,217.6 Mn by the end of 2033, up from its current estimated market size of ~US$ 11,357.8 Mn in 2023.
| Attributes | Key Insights |
|---|---|
|
Global Medical Footwear Market Size (2022A) |
~US$ 10,601.5 Mn |
|
Global Medical Footwear Market Size (2023E) |
~US$ 11,357.8 Mn |
|
Projected Sales of Medical Footwear Market (2032F) |
~US$ 19,217.6 Mn |
|
Value CAGR (2023 to 2033) |
~5.4% |
|
Collective Value Share: Top 3 Countries (2022) |
~30.5% |
The revolutionizing nature of the market is pushing a number of major companies to sell medical footwear with anti-fungal qualities due to ongoing product innovation. Additionally, some businesses are even growing their product line-up.
For instance, ASICS has unveiled a new range of shoes designed especially for medical professionals who are always on the go. The recently created medical professional footwear aims to satisfy the fundamental functional requirements of the medical and nursing care industries, as well as the functionality of athletic materials and cutting-edge technologies that promote easier body mobility.
A great number of start-up companies are focusing their resources towards development and testing the new technology that projects prominent improvement in consumer adaptability. The products are highly focused towards patients with orthotic issues in order to help them prevent any further injury or mishap. The market is witnessing growth on the back of such factors and the same trend is anticipated to boost the market during the forecast period.
Historically from 2017 to 2022, use of medical footwear increased at around 3.9% CAGR, with the U.S., China, Germany, and U.K. holding significant share in the global market.
Specially made footwear that aids in the treatment of various foot-related medical conditions is referred to as medical footwear. A few of the conditions include arthritis, plantar fasciitis, bunions, hallux valgus, and Achilles tendinitis. Diabetes patients and people with flat feet can both gain from it.
More people are purchasing high-quality medical footwear that cushions the entire foot while promoting mobility, support, and healthy blood circulation as a result of rising physical ailments, sports injuries, and muscle pain as well as medical conditions like foot and ankle injuries, fungal infections, flat feet, and arthritis. Additionally, it is anticipated that greater individual understanding of proper foot care will encourage the use of these shoes.
Inappropriate footwear use, which affects between 25% and 30% of diabetes people, is the leading cause of diabetic foot ulcers. According to The International Working Group on Diabetic Foot, wearing inappropriate footwear or walking barefoot are the main contributors to foot trauma that results in foot ulcers in individuals with diabetes and insensate feet.
Patients who suffer from medical conditions like diabetes are among those who utilise therapeutic footwear the most frequently. These people are particularly vulnerable to foot problems and the disease known as neuropathy because of the damage that poorly controlled blood sugar can do to many different body parts, including the nerves and capillaries that lead to the feet. A medical shoe is designed expressly to help lower risk and improve healthy blood circulation, mobility, and foot support.
Numerous improvements and alterations have been made to medical footwear as a result of the expansion of the footwear market. Manufacturers are focusing on developing more sophisticated medical footwear.
For instance, Watts Footwear specialises in creating distinctive shoes for usage in areas where sanitation is essential. Medical clogs and shoes made by Watts Footwear are hygienic and pleasant. They are made of flexible, lightweight material and available in unique women's and men's variants with four different interchangeable insoles.
This also means that they have Microban technology, which works around-the-clock to prevent dangerous bacteria from forming on the shoe's surface, and that they are exceptionally comfortable to walk in and fit every foot precisely.
Will Growth of Affluent Aging Population in the United States Drive Product Adoption?
The U.S. market held a market share of around 18.4% in the global industry in 2022. Seventy-five percent of Americans experience foot issues at some point in their lives, according to Orthopaedic Associates. Over 2 million Americans get plantar fasciitis (heel soreness) each year. Four times as many women experience foot problems as males do. High heels can be blamed for some of the problem.
Additionally, as the population of the United States ages, more people are developing ailments including diabetes, osteoarthritis, high blood pressure, body aches, stiffness, and dementia. The aged, obese, females, and individuals with diabetes, heart disease, osteoporosis, knee, hip, or back pain are far more likely to experience foot issues. Women are much more likely than males to experience pain in their toes and foot's ball. Medical footwear will help to reduce the occurrence of the disorders listed above, which will increase market reach.
How is Growing Health Issues such as Diabetics Driving Product Sales in Germany?
Germany held a 4.9% share of the global market in 2022, and is predicted to continue to expand quickly. According to the International Diabetes Federation (IDF), 59 million persons (20-79 years) in the IDF Europe Region were expected to have diabetes in 2019. With a total of 296,500 cases, the Region has the highest percentage of kids and teenagers (0–19 years) who have type 1 diabetes.
Diabetes affects 463 million people globally, including more than 59 million in the EUR region, with a predicted increase to 68 million by 2045. Germany is one of the 57 countries in the IDF EUR zone. The need for medical footwear is expected to increase as the nation's diabetic population grows.
Why is Demand for Medical Footwear Increasing in China?
China is anticipated to grow with a rate of 8.5% CAGR during the forecast period. Some of the main factors influencing the market's revenue growth include early acceptance of new technologies, a significant presence of important competitors, and rising fitness and wellness concerns.
Additionally, the rising number of diabetics in China is projected to increase demand for medical footwear. According to the International Diabetes Federation, this has caused China's prevalence of diabetes to increase to 10.9%. In 2019 estimates place the number of Chinese people with diabetes at 116 million, placing them at danger of fatal outcomes.
Out of 116 million people, more than 65 million were undiagnosed, which increased their risk. An estimated 463 million adults worldwide have diabetes, including 163 million in the Western Pacific Region. Up to 90% of all instances of diabetes are type 2 cases.
How is the Medical Footwear Market Faring in India?
The medical footwear market in India is anticipated to grow at a remarkable CAGR of 10.2%. Customers increasingly favour buying footwear with cutting-edge technical fabrications that offer maximum comfort with a variety of quality and styles alleviation from serious foot problems.
This increase can be attributed to evolving aesthetic trends. In addition, growing consumer health consciousness is boosting demand for medical footwear, including shoes and slippers, which is helping the market growth.
Why is Demand for Medical Shoes & Boots a Key to Revenue Generation?
Medical shoes and boots made up 60.7% of the market's sales in terms of product type in 2022. People who have significant joint pain or foot pain frequently use medical shoes and boots. It is recommended that people with certain medical conditions, such as diabetes, use these shoes.
More people are projected to buy medical shoes and boots as the number of diabetic patients globally rises, which is anticipated to raise demand for medical shoes over the forecast period.
For instance, Drewshoe, Inc. manufactures footwear with removable insoles that may be changed out for custom orthotics to help relieve pressure and pressure points. The shoes have a large shank area to better suit diabetic feet. Shoes lined with deerskin or other gentle, seamless textiles help to minimise foot ulcers, while soft, tumbled leathers help to lessen inflammation.
Which Consumer Orientation Drives Most Demand for Medical Footwear?
Women category is predicted to contribute the highest value share with 60.9% market share in 2022. It is anticipated that more women will participate in outdoor sports like jogging, climbing, and other adventure activities, which will increase demand for medical footwear to lessen knee pain and injury. To supply customers with appropriate medical footwear, well-established businesses have focused on research and development.
Which Price Range Hold Lucrative Avenues for Medical Footwear?
Price-wise, US$ 100-200 category is anticipated to experience a substantial CAGR of 7.6% throughout the course of the forecast year. As these types of medical footwear offer a multitude of benefits, including relief from joint pain, knee discomfort, and back pain, among others.
Additionally, because foot problems are becoming more prevalent, industry participants are concentrating on offering affordable medical footwear to consumers.
Market participants are developing new strategies to launch their products in various geographic areas. The increased competition is the reason for these actions and efforts. Established businesses are carefully examining their marketing tactics. Innovation in products, partnerships, and collaborations are all strongly influencing market expansion.
A persistent trend in this area will be the development of new strategic alliances with key players or suppliers in order to acquire significant market presence.
| Attribute | Details |
|---|---|
|
Forecast Period |
2023-2033 |
|
Historical Data Available for |
2017-2022 |
|
Market Analysis |
|
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Customization & Pricing |
Available upon Request |
By Product Type
By Consumer Orientation
By Price Range
By Sales Channel
To know more about delivery timeline for this report Contact Sales
The global market for medical footwear is valued at US$ 10,601.4 Mn.
Holding more than 30%-40% market share, DJO, LLC (Dr. Comfort), Drewshoe, Incorporated, Orthofeet Inc., DARCO International, Inc., Clearwell Mobility Company are the top 5 manufacturers of medical footwear.
The global market for medical footwear increased at 3.9% CAGR from 2017 to 2022.
Key trends in this industry include the growing popularity of online stores, new product releases, and increased mergers and acquisitions.
North America held a significant share of 25.3% in 2022, and is expected to rise at a CAGR of 2.8% through 2033.
Key exporters of medical footwear are China, the U.S., U.K., and Germany.
Market analysis reveals that year-on-year demand growth in U.K. will be 2.2% by 2033, whereas, the market in Japan held a market share of 7.2% in the global market in 2022.
